Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Volumn 22, Issue 7, 2016, Pages 1596-1608

  Tom, Michael R ^a   Li, Ji ^a,b   Ueno, Aito ^a   Fort Gasia, Miriam ^a   Chan, Ronald ^a   Hung, Daniel Y ^a   Chenoo, Shem ^a   Iacucci, Marietta ^a   Jijon, Humberto B ^a   Kaplan, Gilaad G ^a   Beck, Paul L ^a   Panaccione, Remo ^a   Barkema, Herman W ^a   Buret, Andre G ^a   Yajnik, Vijay ^c   Ghosh, Subrata ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CD8+ T cells; Crohn's disease; T cell plasticity; ulcerative colitis

Indexed keywords

AZATHIOPRINE; CALCITRIOL; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 17; MESALAZINE; METHOTREXATE; TRANSCRIPTION FACTOR FOXP3; VITAMIN D; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; VITAMIN;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CROHN DISEASE; ENVIRONMENTAL FACTOR; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASTICITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TC17 CELL; TCREG CELL; ULCERATIVE COLITIS; AGED; BIOPSY; CASE CONTROL STUDY; CELL PLASTICITY; DRUG EFFECTS; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; TH17 CELL; YOUNG ADULT;

ADULT; AGED; BIOPSY; CALCITRIOL; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PLASTICITY; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTESTINAL MUCOSA; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VITAMINS; YOUNG ADULT;

EID: 84976272008     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000848     Document Type: Article

References (67)

1. Sarkar S, Hewison M, Studzinski GP, et al. Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer. Crit Rev Clin Lab Sci. 2015:1-14
2. Shrikant PA, Rao R, Li Q, et al. Regulating functional cell fates in CD8 T cells. Immunol Res. 2010;46:12-22
3. Roberts-Thomson IC, Fon J, Uylaki W, et al. Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol. 2011;5:703-716
4. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-1767
5. Buchwald ZS, Kiesel JR, DiPaolo R, et al. Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro. PLoS One. 2012;7: e38199
6. Wang RF. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. Hum Immunol. 2008;69:811-814
7. Mittrucker HW, Visekruna A, Huber M. Heterogeneity in the differentiation and function of CD8(+) T cells. Arch Immunol Ther Exp (Warsz). 2014;62:449-458
8. Carvalheiro H, Silva JA, Souto-Carneiro MM. Potential roles for CD8 (+) T cells in rheumatoid arthritis. Autoimmun Rev. 2013;12:401-409
9. Zozulya AL, Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum Immunol. 2008; 69:797-804
10. Rocchi A, Benchimol EI, Bernstein CN, et al. Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol. 2012;26: 811-817
11. Iboshi Y, Nakamura K, Ihara E, et al. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2014;20:967-977
12. Xu XR, Liu CQ, Feng BS, et al. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2014;20:3255-3264
13. Granlund A, Flatberg A, Ostvik AE, et al. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis. PLoS One. 2013;8:e56818
14. Ueno A, Jijon H, Chan R, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19:2522-2534
15. Sawant DV, Vignali DA. Once a Treg, always a Treg?. Immunol Rev. 2014;259:173-191
16. Liu HP, Cao AT, Feng T, et al. TGF-beta converts Th1 cells into Th17 cells through stimulation of Runx1 expression. Eur J Immunol. 2015;45: 1010-1018
17. Lee JC, Lyons PA, McKinney EF, et al. Gene expression profiling of CD8 + T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J Clin Invest. 2011;121:4170-4179
18. Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet. 2015;47:172-179
19. Ikeda U, Wakita D, Ohkuri T, et al. 1 alpha, 25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett. 2010;134:7-16
20. Imazeki I, Matsuzaki J, Tsuji K, et al. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res. 2006;27:1-9
21. Ardizzone S, Cassinotti A, Trabattoni D, et al. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol. 2009; 22:63-71
22. Urry Z, Chambers ES, Xystrakis E, et al. The role of 1a, 25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3(+) and IL-10(+) CD4(+) T cells. Eur J Immunol. 2012;42: 2697-2708
23. Raman M, Milestone AN, Walters JR, et al. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol. 2011;4:49-62
24. Chen J, Bruce D, Cantorna MT. Vitamin D receptor expression controls proliferation of naive CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 2014;15:6
25. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629
26. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514
27. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194-1201
28. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc. 2004;60:505-512
29. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99: 956-963
30. Ueno A, Ghosh A, Hung D, et al. Th17 plasticity and its changes associated with inflammatory bowel disease. World J Gastroenterol. 2015;21: 12283-12295
31. Funderburg NT, Stubblefield Park SR, Sung HC, et al. Circulating CD4 (+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology. 2013; 140:87-97
32. Olsen T, Rismo R, Cui G, et al. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine. 2011;56:633-640
33. Dong Z, Du L, Xu X, et al. Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis. Int J Mol Med. 2013;31:989-997
34. Zhou H, Hua W, Jin Y, et al. Tc17 cells are associated with cigarette smoke-induced lung inflammation and emphysema. Respirology. 2015; 20:426-433
35. Teunissen MB, Yeremenko NG, Baeten DL, et al. The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosaassociated invariant T cells and conventional T cells. J Invest Dermatol. 2014;134:2898-2907
36. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 2009;58:1152-1167
37. Boer MC, van Meijgaarden KE, Joosten SA, et al. CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One. 2014;9:e94192
38. Raja KR, Kubiczkova L, Rihova L, et al. Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment. PLoS One. 2012;7:e49446
39. Raja KR, Plasil M, Rihova L, et al. Flow cytometry-based enumeration and functional characterization of CD8 T regulatory cells in patients with multiple myeloma before and after lenalidomide plus dexamethasone treatment. Cytometry B Clin Cytom. 2014;86: 220-228
40. Fernandes C, Goncalves HS, Cabral PB, et al. Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy. PLoS One. 2013;8:e79072
41. Brimnes J, Allez M, Dotan I, et al. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol. 2005;174:5814-5822
42. Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn's disease patients. World J Gastroenterol. 2013;19:3931-3941
43. Li B, Gurung P, Malireddi RK, et al. IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis. Nat Commun. 2015;6:6131
44. Wilke CM, Wang L, Wei S, et al. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. J Transl Med. 2011;9:217
45. Globig A, Hennecke N, Martin B, et al. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-g+IL-17+ coproducing CD4+ T cells in active inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:2321-2329
46. Tajima M, Wakita D, Satoh T, et al. IL-17/IFN-gamma double producing CD8+ T (Tc17/IFN-gamma) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int Immunol. 2011;23:751-759
47. Cosmi L, Liotta F, Maggi E, et al. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin. Int Arch Allergy Immunol. 2014;164:171-177
48. Harbour SN, Maynard CL, Zindl CL, et al. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci U S A. 2015;112:7061-7066
49. Li L, Boussiotis VA. The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clin Immunol. 2013;148: 246-253
50. Takahashi R, Yoshimura A. SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res. 2014;2014:943149
51. Yang BH, Hagemann S, Mamareli P, et al. Foxp3 T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 2015. doi: 10.1038/mi.2015.74 [epub ahead of print]
52. Sharma MD, Huang L, Choi JH, et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity. 2013;38:998-1012
53. Baeke F, Etten EV, Overbergh L, et al. Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev. 2007;20:106-118
54. Lim WC, Hanauer SB, Li YC. Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005; 2:308-315
55. Gonzalez-Mateo GT, Fernandez-Millara V, Bellon T, et al. Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production. PLoS One. 2014;9: e108477
56. Guillot X, Semerano L, Saidenberg-Kermanac'h N, et al. Vitamin D and inflammation. Joint Bone Spine. 2010;77:552-557
57. Jeffery LE, Wood AM, Qureshi OS, et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol. 2012;189:5155-5164
58. Dyring-Andersen B, Bonefeld CM, Bzorek M, et al. The vitamin D analogue calcipotriol reduces the frequency of CD8+ IL-17+ T cells in psoriasis lesions. Scand J Immunol. 2015;82:84-91
59. Peelen E, Thewissen M, Knippenberg S, et al. Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators. J Neuroimmunol. 2013;258:77-84
60. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease-A randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377-383
61. Miheller P, Muzes G, Hritz I, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis. 2009;15: 1656-1662
62. Nicholson I, Dalzell AM, El-Matary W. Vitamin D as a therapy for colitis: a systematic review. J Crohns Colitis. 2012;6:405-411
63. Reich KM, Fedorak RN, Madsen K, et al. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol. 2014;20:4934-4947
64. Bartels LE, Jorgensen SP, Bendix M, et al. 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease. Inflammopharmacology. 2013;21:177-186
65. Bartels LE, Bendix M, Hvas CL, et al. Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients. Inflammopharmacology. 2014; 22:95-103
66. Cantorna MT, Snyder L, Lin YD, et al. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7:3011-3021
67. Raftery T, Martineau AR, Greiller CL, et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: results from a randomised double-blind placebo-controlled study. United European Gastroenterol J. 2015;3:294-302